Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy (Q38045203)

27 August 2017

Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy (English)

1 reference

27 August 2017

B Maisch

1

1 reference

PubMed ID

22996288

27 August 2017

S Pankuweit

series ordinal

2

1 reference

PubMed ID

22996288

27 August 2017

language of work or name

1 reference

1 September 2012

1 reference

27 August 2017

1 reference

27 August 2017

37

1 reference

27 August 2017

6

1 reference

27 August 2017

644-656

1 reference

Cardiomyopathies: classification, diagnosis, and treatment

27 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Clinical aspects of cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. A status report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Inflammatory dilated cardiomyopathy (DCMI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Prevalence of viral genome in endomyocardial biopsies from patients with inflammatory heart muscle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Many roads lead to a broken heart: the genetics of dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Myocarditis and dilated cardiomyopathy An inflammatory link

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Dilated cardiomyopathy: a genetically heterogeneous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

[Classification of cardiomyopathies and indication for endomyocardial biopsy revisited].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Molecular etiology and pathogenesis of hereditary cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Innate immunity and inflammation--New frontiers in comparative cardiovascular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Management of patients with suspected (peri-)myocarditis and inflammatory dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Dilated cardiomyopathies as a cause of congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Human viral cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Prognostic determinants in conventionally treated myocarditis and perimyocarditis--focus on antimyolemmal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Predictors of outcome in patients with suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Integrated biomarkers in cardiomyopathies: cardiovascular magnetic resonance imaging combined with molecular and immunologic markers--a stepwise approach for diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Autoantibodies and serum inhibition factors (sif) in patients with myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Assessment of antibody mediated cytolysis of adult cardiocytes isolated by centrifugation in a continuous gradient of percollTM in patients with acute myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Pathophysiology of viral myocarditis: the role of humoral immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Acute effect of calcium channel blockers on adriamycin exposed isolated adult cardiocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Antibodies against stress proteins in sera of patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Antibodies to human sinus node in sick sinus syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Humoral immune response to cardiac conducting tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Diabetes and idiopathic cardiomyopathy: a nationwide case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Invasive techniques--from diagnosis to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Epidemiology and estimated population burden of selected autoimmune diseases in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Sex differences in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Images in cardiovascular medicine. Phenotype of infiltrating T lymphocytes in cardiac sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Pathogenesis of group A streptococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Autoantibodies in the sera of patients with rheumatic heart disease: characterization of myocardial antigens by two-dimensional immunoblotting and N-terminal sequence analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

T cell mimicry and epitope specificity of cross-reactive T cell clones from rheumatic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

PDIA3, HSPA5 and vimentin, proteins identified by 2-DE in the valvular tissue, are the target antigens of peripheral and heart infiltrating T cells from chronic rheumatic heart disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Cardiac toxicity from systemic cancer therapy: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Mechanisms and management of doxorubicin cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Cardiac side effects of conventional and particle radiotherapy in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

The management of myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Coxsackievirus B3 infection leads to cell death of cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Expression of major histocompatibility complex class I antigen in murine ventricular myocytes infected with Coxsackievirus B3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Expression of intercellular adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Identification of autoantibodies with the corresponding antigen for repetitive coxsackievirus infection-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Characterization of anti-heart antibodies in mice after infection with coxsackie B3 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Myocarditis caused by parvovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Human herpesvirus-6: a short review of its biological behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Is human herpesvirus-6 a trigger for chronic fatigue syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Clinicopathologic description of myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Cardiovascular magnetic resonance in myocarditis: A JACC White Paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Diagnosis of myocarditis: death of Dallas criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

A comparison of rate control and rhythm control in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

21 January 2018

Myocarditis in autopsy.

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Recurrence of giant cell myocarditis in cardiac allograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Sarcoidosis is associated with a truncating splice site mutation in BTNL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Sarcoid heart disease: clinical course and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Eosinophilia and heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Relation between eosinophilia and endomyocardial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

The cardiotoxicity of eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Clinical and echocardiographic features of hypereosinophilic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Evaluation of cardiac involvement in hypereosinophilic syndrome: complementary roles of transthoracic, transesophageal, and contrast echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Hypereosinophilic Syndrome: a rare case of Loeffler's endocarditis documented in cardiac MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Magnetic resonance imaging for endomyocardial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Time course of eosinophilic myocarditis visualized by CMR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome: a phase-II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Mepolizumab in eosinophilic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Treatment of patients with the hypereosinophilic syndrome with mepolizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Pathology and natural history of human myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Intravenous immunoglobulin in autoimmune neuromuscular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Anti-inflammatory actions of intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Putative mechanisms of the effect of intravenous gamma-globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

The role of intravenous immunoglobulin in the treatment of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

A systematic review of intravenous gamma globulin for therapy of acute myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

High-dose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Pediatric patients hospitalized with myocarditis: a multi-institutional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Varicella myocarditis in an adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

beta(1)-Adrenoceptor antibodies induce positive inotropic response in isolated cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus b19 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone; the way to avoid side effects of systemic corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

FATAL COXSACKIEVIRUS A16 INFECTION

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Immunoadsorption and subsequent immunoglobulin substitution decreases myocardial gene expression of desmin in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Gamma-globulin treatment of acute myocarditis in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-012-3679-9

Cytotoxic properties of the eosinophil major basic protein

21 January 2018

1 reference

12 December 2020

Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops

1 reference

12 December 2020

Clinical and histopathological profile of sarcoidosis of the heart and acute idiopathic myocarditis. Concepts through a study employing endomyocardial biopsy. I. Sarcoidosis

1 reference

12 December 2020

Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart A

1 reference

12 December 2020

Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders

1 reference

12 December 2020

[Myocardial fibrosis: a cardiopathophysiologic Janus head]

1 reference

12 December 2020

Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy

1 reference

12 December 2020

Diagnosis of active lymphocytic myocarditis by endomyocardial biopsy: quantitative criteria for light microscopy

1 reference

12 December 2020

Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators

1 reference

12 December 2020

Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis

1 reference

12 December 2020

Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice

1 reference

12 December 2020

Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens

1 reference

12 December 2020

Murine natural killer cells limit coxsackievirus B3 replication

1 reference

12 December 2020

Cytolytic anticardiac membrane antibodies in the pathogenesis of myopericarditis

1 reference

12 December 2020

Oral administration of candesartan improves the survival of mice with viral myocarditis through modification of cardiac adiponectin expression

1 reference

12 December 2020

Intravenous immune globulin in the therapy of peripartum cardiomyopathy

1 reference

12 December 2020

Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution

1 reference

12 December 2020

Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease

1 reference

12 December 2020

2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Deve

1 reference

12 December 2020

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy

1 reference

12 December 2020

Long survival with giant cell myocarditis

1 reference

12 December 2020

Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial

1 reference

12 December 2020

A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation

1 reference

12 December 2020

1 reference

12 December 2020

T-cell receptor V beta gene expression in infiltrating cells in murine hearts with acute myocarditis caused by coxsackievirus B3

1 reference

12 December 2020

[Alcohol and myocarditis]

1 reference

12 December 2020

Cardiac imaging in rheumatic diseases

1 reference

12 December 2020

Surface antigens of adult heart cells and their use in diagnosis

1 reference

12 December 2020

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure

1 reference

12 December 2020

Parvovirus B19 infection during pregnancy treated with high-dose intravenous gammaglobulin

1 reference

12 December 2020

Clinical study on therapeutic effects of treatment according to syndrome differentiation of traditional Chinese medicine combined with captopril on severe viral myocarditis complicated heart failure

1 reference

12 December 2020

Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure

1 reference

12 December 2020

Implications of the Myocarditis Treatment Trial for clinical practice.

1 reference

12 December 2020

Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect

1 reference

12 December 2020

The cardiomyopathies: a report of fifty cases

1 reference

12 December 2020

Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting

1 reference

12 December 2020

Exercise testing in the indication and evaluation of pacemaker treatment

1 reference

12 December 2020

Diabetic cardiomyopathy--fact or fiction?

1 reference

12 December 2020

Prolonged bed rest in the treatment of ischemic cardiomyopathy

1 reference

12 December 2020

[Hypertension and alcohol: central and peripheral mechanisms]

1 reference

12 December 2020

Alcohol and the heart

1 reference

12 December 2020

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology

1 reference

12 December 2020

A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy

1 reference

12 December 2020

Discovery and development of antipicornaviral agents.

1 reference

12 December 2020

Idiopathic Giant Cell Myocarditis

1 reference

12 December 2020

Sensitivity and Specificity of Echocardiographic Diagnosis of Pericardial Effusion

1 reference

12 December 2020

Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease

1 reference

12 December 2020

Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy

1 reference

12 December 2020

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

12 December 2020

Vaccination of Balb/c mice against enteroviral mediated myocarditis

1 reference

12 December 2020

High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis

1 reference

12 December 2020

Does CMV infection play a role in myocarditis? New aspects from in-situ hybridization

1 reference

12 December 2020

Successful immunoglobulin treatment for fulminant myocarditis and serial analysis of serum thioredoxin: a case report

1 reference

12 December 2020

Human parvovirus B19-associated myocarditis

1 reference

12 December 2020

Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress

1 reference

12 December 2020

Immunological cellular regulator and effector mechanisms in myocarditis.

1 reference

12 December 2020

Cardiac sarcoidosis: cytokine patterns in the course of the disease.

1 reference

12 December 2020

Heart involvement in autoimmune rheumatic diseases: the "phantom of the opera"

1 reference

12 December 2020

Characterization of Löeffler eosinophilic myocarditis by means of real time three-dimensional contrast-enhanced echocardiography

1 reference

12 December 2020

Expression of costimulatory molecules B7-1, B7-2, and CD40 in the heart of patients with acute myocarditis and dilated cardiomyopathy

1 reference

12 December 2020

A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy

1 reference

12 December 2020

Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease

1 reference

12 December 2020

Intravenous gamma-globulin therapy in myocarditis complicated with complete heart block: Report of one case

1 reference

12 December 2020

Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies

1 reference

12 December 2020

Giant cell myocarditis responding to immunosuppressive therapy

1 reference

12 December 2020

Quantification of antimyosin antibodies in experimental myocarditis by a new solid phase fluorometric assay

1 reference

12 December 2020

Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases

1 reference

12 December 2020

The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID)

1 reference

12 December 2020

[Women and autoimmune diseases with cardiovascular manifestations]

1 reference

12 December 2020

Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis

1 reference

12 December 2020

Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects

1 reference

12 December 2020

Cardiovascular disease in cancer patients… only the tip of the iceberg?

1 reference

12 December 2020

Isolated cardiac sarcoidosis associated with the expression of a splice variant coding for a truncated BTNL2 protein

1 reference

12 December 2020

Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Characterization and pathogenetic relevance.

1 reference

12 December 2020

Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy

1 reference

12 December 2020

Heart disease and the eosinophil

1 reference

12 December 2020

Successful treatment of severe heart failure caused by idiopathic giant cell myocarditis

1 reference

12 December 2020

Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction

1 reference

12 December 2020

High-dose immunoglobulin G therapy for fulminant myocarditis

1 reference

12 December 2020

Are antisarcolemmal (ASAs) and antimyolemmal antibodies (AMLAs) "natural" antibodies?

1 reference

12 December 2020

Treatment of viral myocarditis with focus on captopril

1 reference

12 December 2020

Identification of mitochondrial antigens recognized by antibodies in sera of patients with idiopathic dilated cardiomyopathy by two-dimensional gel electrophoresis and protein sequencing

1 reference

12 December 2020

Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study

1 reference

12 December 2020

Assessment of cytomegalovirus DNA and protein expression in patients with myocarditis

1 reference

12 December 2020

Autoreactivity to the cardiac myocyte, connective tissue and the extracellular matrix in heart disease and postcardiac injury.

1 reference

12 December 2020

Diagnosis and classification of myocarditis by endomyocardial biopsy

1 reference

12 December 2020

Cellular Immune Mechanisms in Coxsackievirus Group B, Type 3 Induced Myocarditis in Balb/C Mice

1 reference

12 December 2020

Association between human herpesvirus type 6 and type 7, and cytomegalovirus disease in heart transplant recipients

1 reference

12 December 2020

Reversible catecholamine-induced cardiomyopathy in a heart transplant candidate without persistent or paroxysmal hypertension

1 reference

12 December 2020

IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction

1 reference

12 December 2020

Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice.

1 reference

12 December 2020

Recently diagnosed idiopathic dilated cardiomyopathy: incidence of myocarditis and efficacy of prednisone therapy

1 reference

12 December 2020

[Obesity, diabetes mellitus and metabolic syndrome: the implications for heart and the vascular system]

1 reference

12 December 2020

Hemodynamic and scintigraphic improvement after steroid therapy in a case with acute eosinophilic heart disease

1 reference

12 December 2020

Recurrent giant cell myocarditis after transplantation

1 reference

12 December 2020

Alcohol and rhythm disturbance: the holiday heart syndrome

1 reference

12 December 2020

Effects of the antiviral WIN 54954 and the immune modulator LS 2616 on cachectin/TNF and gamma-interferon responses during viral heart disease.

1 reference

12 December 2020

Giant cell myocarditis, in a patient with Crohn's disease, treated with etanercept--a tumour necrosis factor-alpha antagonist

1 reference

12 December 2020

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

12 December 2020

A fatal case of fulminant myocarditis with human herpesvirus-6 infection

1 reference

12 December 2020

Rat dilated cardiomyopathy after autoimmune giant cell myocarditis

1 reference

12 December 2020

Immunomodulating factors and immunosuppressive drugs in the therapy of myocarditis.

1 reference

12 December 2020

Myocarditis: the Dallas criteria

1 reference

12 December 2020

10.1007/S00059-012-3679-9

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

22996288